inflammatory exudate, cerebral edema, increased intracranial pressure, and alteration of cerebral blood flow (2, 3) . TNF and IL-I have been demonstrated in the CSF of neonates and children with bacterial meningitis (4) . High levels of IL-1 in the CSF of these patients correlate with the development of neurologic complications (5, 6) . IL-8 enhances chemotaxis, attachment to endothelial cells, and diapedesis of leukocytes (7) .
Release of bacterial surface structures due to treatment with antibiotics is probably responsible for the high morbidity and mortality during bacterial meningitis (8, 9) .
To improve treatment of bacterial meningitis, many experimental and clinical studies have focused on adjunctive therapy with glucocorticosteroids, PTX, and MAb against endotoxin to limit inflammation and sequelae (10) (11) (12) (13) (14) . Some of these compounds might be effective on the release of proinflammatory mediators. The aim of the present study was to compare the effects of DXM, PTX, and MAb against endotoxin on the release of proinflammatory mediators and PGE2 by human leukocytes during stimulation with H. injluenzae in vitro.
MATERIALS AND METHODS
Microorganisms. H. injluenzae (strain 760705) (a generous gift from Dr. L. van Alphen, Academic Medical Center, Amsterdam, The Netherlands) was cultured for 18 h at 37'C in Miiller-Hinton broth containing 4% factor V and 0.08% factor X. The bacteria were collected by centrifugation (10 min; 1500 x g), washed twice with PBS (pH 7.4), and suspended at appropriate bacterial concentrations in PBS. Bacteria were killed by incubation at 70'C for 1 h. After centrifugation of 5 x lo6 heat-killed bacteria (10 min; 1500 x g) and filtration through a Millipore filter (4 rM, Millipore, Costar, Cambridge, MA), the cell-free supernatant contained 16 rg/L free LPS.
Isolation of Monocytes. Monocytes were isolated from the buffy coats of blood from healthy donors by differential centrifugation on Ficoll-Hypaque gradients ( p = 1.077 kg/L, Pharmacia, Upsala, Sweden). The interphase with mononuclear cells was washed with PBS containing 5 x lo2 U/L heparin and suspended in medium to a concentration of 3-4 x 101° cells per L. This suspension contained 30-35% monocytes and less than 2% granulocytes. Cell viability exceeded 98%, as determined by trypan blue exclusion. All experiments were performed in siliconized glassware to prevent adherence of the monocytes to the glass surface.
Monocytes were purified from the Ficoll-Hypaque interphase by adherence or elutriation.
Isolation of monocytes by adherence. Isolation of monocytes by elutriation. Monocytes were purified from the Ficoll-Hypaque interphase by countercurrent centrifugal elutriation in a Beckmann 52-2 1 M/E centrifuge using a JE-6 elutriation rotor (Beckmann Instruments, Palo Alto, CA). The suspension contained 80-90% pure monocytes.
All materials contained less than 20 pg LPS, as determined by the Limulus lysate assay.
Isolation of Granulocytes and Lymphocytes. Granulocyte suspensions were isolated from the Ficoll-Hypaque pellets from which erythrocytes had been removed by sedimentation with Plasmasterile (Fresenius AG, Bad Homburg, Germany) for 10 min at 1 x g a t 37°C. Residual erythrocytes were lysed once with distilled water for 30 s at 4"C, and the remaining granulocytes were washed with PBS and resuspended in medium. These cell preparations contained virtually no erythrocytes and yielded at least 98% granulocytes with less than 2% monocyte contamination. Lymphocytes were purified from the Ficoll-Hypaque interphase by countercurrent centrifugal elutriation in a Beckmann 52-2 1 M/E centrifuge using a JE-6 elutriation rotor. The suspensions yielded greater than 80% lymphocytes with less than 9% monocyte contamination. Granulocytes and lymphocytes were more than 95% viable, as assessed by trypan blue exclusion.
Stimulation of Release of Mediators. Fresh heparinized (lo4 U/L) blood from healthy volunteers was diluted 5-fold with RPMI containing lo5 U/L penicillin and 50 mg/L streptomycin. One-mL aliquots of blood were incubated with 5 x lo6 heatkilled H. influenzae in 24-well tissue culture plates for 18 h at 37°C at 7.5% C02; the suspension was then centrifuged (10 min; 1500 x g); the resulting supernatant was collected, filtered (Millipore, Costar) and used to quantify the mediators under study. The same experiment was performed with monocytes, isolated by adherence or elutriation, elutriated lymphocytes, and granulocytes; a concentration of 5 x 10' cells/L was incubated with 1 x 1OY/L heat-killed H. influenzae in 1 mL of medium for 18 h. For description of experimental conditions and collection and assessment of the supernatant, see above.
Measurement of Proinflammatory Mediators. The concentrations of TNF, IL-IP, and IL-8 in plasma or supernatant were measured by means of ELISA according to instructions from the manufacturer (Amersham, Bucks, UK). After removal of proteins from the plasma or supernatant by ethanol extraction, PGE2 was extracted by means of a C18 octadecyl column (Amersham) and assessed by RIA (Amersham).
Inhibition of Release of Mediators. Various concentrations of DXM (MSD, Haarlem, The Netherlands), PTX (Hoechst AG, Wiesbaden, Germany), and anti-endotoxin MAb (HA-I A) (Centocor, Leiden, The Netherlands) were used for the incubation of blood as well as the suspension of isolated leukocytes and adherent monocytes. The amount of proinflammatory mediators was then measured as described above.
Binding of HA-1A to H. influenzae. Binding of HA-I A to H. influenzae was measured by ELISA. In short, microwells (Nunclon plates, Interned, Roskilde, Danmark) were coated by overnight incubation with 1 x lo7 heat-killed H. influenzae in carbonate buffer (pH 9.6) at room temperature. After washing with PBS containing 0.05% Tween-20 (PBS-Tween), nonspecific binding sites were blocked by incubating the wells for 30 min with 100 gL of 10% heat-inactivated newborn calf serum in PBSTween at room temperature. Next, wells were incubated for 60 min with 100 pL of HA-IA in PBS-Tween in serial dilutions from 100 pg to 1000 pg/L, then washed and incubated with an optimal dilution of 100 pL of goat-anti-human IgM conjugated to horseradish peroxidase (Nordic, Tilburg, The Netherlands). Tetramethylbenzidine was used as a substrate for the horseradish peroxidase, and absorption was measured at 450 nm. As a control, wells were incubated with human IgM instead of HA-IA.
Statistical Analysis. The results are expressed as medians and 95% intervals of at least four to seven experiments unless otherwise stated. The significance of the differences between values was determined by the Mann-Whitney U test. The level of significance was set at 0.05.
RESULTS
Release of various proinflammatory mediators by leukocytes in whole blood stimulated by H. influenzae. Incubation of whole blood with heat-killed H. influenzae resulted in the time-dependent release of various proinflammatory mediators into the culture supernatant (Fig. 1) . TNF was already detectable after 3 h of incubation. Peak levels were reached at 6 h; the concentration of TNF subsequently decreased. After 3 h of incubation, IL-IS was not detectable; concentrations were maximal at 6 h and remained high for 18 h. Increasing levels of IL-8 and PGE2 were found during the 24-h incubation period; therefore, in subsequent experiments the concentrations of the proinflammatory mediators were determined at 18 h.
Effect of DXM on release of proinflammatory mediators. After 18 h of stimulation of leukocytes in whole blood with heat-killed H. influenzae, high concentrations of the proinflammatory mediators TNF, IL-Ip, IL-8, and PGE2 were present. When 0.5 mg/ L or 0.1 mg/L DXM was added, there was a significant ( p < 0.05) decrease in the release of these proinflammatory mediators.
The percentages of decrease at 18 h were 96 * 3% for TNF, 73 + 24% for IL-IP, 75 f 15% for IL-8, and 96 f 5% for PGE2 (Fig. 2) . A similar decrease in cytokine release was found when adherent monocytes were stimulated with H. influenzae in the presence of DXM, i.e. a 72 f 14% decrease in TNF, a 63 + 22% decrease in IL-8, and a 77 f 13% decrease in PGE2; in contrast, IL-IS exhibited a decrease of only 24 f 22%, which was not significant (Fig. 2) .
Effect of PTX on release of proinflammatory mediators. Whole blood incubated with heat-killed H. influenzae and 100 mg/L PTX resulted in a significant ( p < 0.05) decrease of 9 1 + 3% in the release of TNF (Fig. 2) . The effect of PTX on the release of TNF was dose dependent, i.e. 10 mg/L caused a decrease in TNF release of 43 + 2 1 % and I mg/L caused a decrease of 12 + 14%. PTX had almost no effect on the release of the other mediators, i.e. IL-ID, IL-8, and PGEz (Fig. 2) , even at concentrations of PTX of 200 mg/L (data not shown). When adherent monocytes were incubated with heat-killed H. influenzae and 100 mg/L PTX, there was a significant ( p < 0.01) reduction in the release of TNF of 92 * 6%, whereas no significant ( p > 0.1) effect on the other mediators was found, 1.e. a 2 1 + 25% decrease in IL-8 release, a 12 + 14% decrease in IL-ID release, and a 6 + 10% decrease in PGEz release (Fig. 2) .
EJfect of anti-endotoxin antibodies (HA-IA) on production of proinflammatory mediators. Whole blood incubated with heatkilled H. influenzae and 40 mg/L HA-1 A reduced the release of TNFby 32 + 18% (p>O.l), IL-1@ by 9 + 12%, and PGEz by 8 + 13%; there was no effect on the release of IL-8 (Fig. 2) Release of cvtokines by isolated monocytes, lymphocytes, and granulocytes. Incubation of elutriated monocytes incubated with heat-killed H. influenzae resulted in a high production of TNF (3.7 pg/L), which was similar to the TNF (3.0 pg/L) produced by a suspension of elutriated monocytes and elutriated lymphocytes stimulated by H. influenzae. Monocytes incubated in medium without H. influenzae did not produce detectable amounts of TNF and IL-I@. Experiments with elutriated lymphocytes, granulocytes, or a combination of elutriated lymphocytes plus granulocytes, all incubated with H. influenzae, revealed no detectable production of TNF (data not shown). IL-ID release by elutriated lymphocytes (22 ng/L) or granulocytes (21 ng/L) stimulated by H. influenzae was negligible.
DISCUSSION
The main conclusion to be drawn from the present study is that DXM reduced the release of the major proinflammatory mediators, i.e. TNF, IL-16, IL-8, and PGE2, by H. influenzaestimulated monocytes, whereas PTX significantly reduced the release of TNF and HA-IA significantly reduced the release of IL-8. The results demonstrate that H. influenzae did not induce the release of TNF by isolated lymphocytes and granulocytes or a combination of lymphocytes and monocytes.
In experimental H. influenzae meningitis, DXM has a beneficial effect on the inflammatory response in the CNS (15) . The mechanism of action of DXM in bacterial meningitis is unknown. It has been suggested that these effects are achieved through inhibition of inflammatory mediators. Our results demonstrate that DXM inhibits the production of a number of 728 VAN 
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mediators in H. influenzae-stimulated whole blood. Similar results were obtained with adherent monocytes stimulated with H. influenzae, although the production of IL-10 was only slightly reduced by DXM. This is in agreement with clinical studies of infants and children with bacterial meningitis treated with antibiotics and DXM: a decrease in TNF, IL-lP, and PGE, levels in CSF and improvement of the outcome of sequelae were found (6, 10, 11). The exact mechanisms by which DXM inhibits the production of proinflammatory mediators are not known. Various processes are influenced by DXM, e.g. it inhibits the translation of TNF mRNA (1 6-18) and LPS-induced IL-1P formation (19).
The present results show that PTX is a rather specific inhibitor of TNF release by human leukocytes, inasmuch as the release of this cytokine, but not of IL-I@, IL-8, and PGE2, was almost completely inhibited. In addition to the decrease in TNF release during bacterial meningitis, PTX also caused reduced leukocyte recruitment into CSF (12) . In healthy volunteers, PTX prevented the elevation of plasma TNF levels after endotoxin infusion (1 3). These antiinflammatory effects might play an important role in the efficacy of PTX in bacterial meningitis in humans.
In the present study, the administration of the anti-endotoxin MAb HA-IA to limit cytokine release by H. influenzae-stimulated leukocytes was investigated. HA-1A binds to the lipid A part of LPS (20) . In vitro studies showed that HA-1A did not inhibit the production of TNF, IL-1, and IL-6 by LPS-stimulated monocytes (2 1) or improve the survival of mice challenged with Gram-negative bacteria or LPS (22) . This is in agreement with our results; HA-IA decreased significantly only the production of IL-8 by adherent monocytes stimulated with H. influenzae, whereas no significant effect of HA-1A on the production of other inflammatory mediators, i.e. TNF, IL-IP, and PGE,, was found. In whole blood stimulated with H. influenzae, HA-IA had no significant effect on the release of these mediators. In patients, HA-IA lowers serum TNF levels (23) and reduces mortality due to Gram-negative bacteremia with shock (14, 23, 24) . It has been reported that HA-1A mediates binding of LPS to complement receptor type 1 on erythrocytes, which in vivo might reduce the levels of circulating LPS, and thus inhibits TNF production (25) . It might be that a similar mechanism occurs during an infection with H. influenzae.
This study shows that, of the three compounds investigated, DXM has the broadest effect. Routine use of DXM is still a subject of controversy among pediatricians, although it seems to decrease both neurologic and audiologic sequelae of H. influenzae meningitis.
